$AMAM - Ambrx Announces Encouraging Preliminary Safety and Efficacy Data Evaluating ARX788 in HER2 Positive Metastatic Breast Cancer Patients Who Progressed Following T-DM1 Treatment: https://finance.yahoo.com/news/ambrx-announces-encouraging-preliminary-safety-130000477.html
$BXRX - Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery: https://finance.yahoo.com/news/baudax-bio-initiates-phase-ii-130000290.html
$NRBO - NEUROBO ANNOUNCES CLOSING OF $32.3 MILLION UNDERWRITTEN PUBLIC OFFERING INCLUDING FULL EXERCISE OF OVERALLOTMENT OPTION AND CONCURRENT PRIVATE PLACEMENT: https://finance.yahoo.com/news/neurobo-announces-closing-32-3-210500773.html